ArticleNeuropsychopharmacology reports2026

Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan.

Hiroaki Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.